https://clinicaltrials.gov/ct2/show/NCT04292730?cond=remdesivir&draw=2&rank=6
A Phase 3 Randomized Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734TM) in Participants with Moderate COVID-19 Compared to Standard of Care Treatment